Liu W, Luo X, Tang J, Mo Q, Zhong H, Zhang H, et al
Compounded GLP-1 medications contain compounded formulations of the active ingredient as brand-name products but aren't the same product, aren't FDA-approved, and should never be represented as equivalent to or interchangeable with FDA-approved medications
Plaintiffs allege that manufacturers Novo Nordisk and Eli Lilly failed to adequately warn patients and healthcare providers about the risks associated with Ozempic and other GLP-1 drugs
This results in bioavailability rates that can be 10-20 times higher than traditional oral glutathione supplements
This mechanism helps to reduce postprandial blood glucose spikes
This can result in firmer bowel movements and a reduction in the rush that often characterizes IBS-D